Covered recipient · General Payments record
ELLIOT THOMAS MIN
Allopathic & Osteopathic Physicians Neurological Surgery
General Payments · PY2018–2024
$52,875.67
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $866.95 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $127.20 | 4 |
| Lilly USA, LLC | $107.19 | 4 |
| KLS-Martin L.P. | $81.51 | 1 |
| Neurelis, Inc. | $77.54 | 4 |
| Alphatec Spine, Inc | $69.49 | 1 |
| Lundbeck LLC | $67.60 | 2 |
| EISAI INC. | $56.79 | 2 |
| ACADIA Pharmaceuticals Inc | $54.94 | 2 |
| Alnylam Pharmaceuticals Inc. | $51.00 | 2 |
| ARGENX US, INC. | $47.53 | 2 |
| ABBVIE INC. | $31.37 | 1 |
| SK Life Science, Inc. | $28.52 | 1 |
| Ipsen Biopharmaceuticals, Inc | $27.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.49 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.37 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105041413 | CMS |
| ACADIA Pharmaceuticals Inc | $23.48 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984434 | CMS |
| ACADIA Pharmaceuticals Inc | $31.46 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984436 | CMS |
| Alnylam Pharmaceuticals Inc. | $22.11 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125849838 | CMS |
| Alnylam Pharmaceuticals Inc. | $28.89 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125849880 | CMS |
| Alphatec Spine, Inc | $69.49 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095489062 | CMS |
| ARGENX US, INC. | $32.37 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142108371 | CMS |
| ARGENX US, INC. | $15.16 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118454 | CMS |
| Eisai Inc. | $25.04 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110743711 | CMS |
| Eisai Inc. | $31.75 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110743713 | CMS |
| Ipsen Biopharmaceuticals, Inc | $27.79 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091981600 | CMS |
| KLS-Martin L.P. | $81.51 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144946479 | CMS |
| Lilly USA, LLC | $21.01 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970463 | CMS |
| Lilly USA, LLC | $28.11 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136156771 | CMS |
| Lilly USA, LLC | $29.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136173840 | CMS |
| Lilly USA, LLC | $28.96 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970531 | CMS |
| Lundbeck LLC | $33.38 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145946850 | CMS |
| Lundbeck LLC | $34.22 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145946852 | CMS |
| Neurelis, Inc. | $24.41 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648424 | CMS |
| Neurelis, Inc. | $13.19 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648426 | CMS |
| Neurelis, Inc. | $23.67 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648428 | CMS |
| Neurelis, Inc. | $16.27 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648430 | CMS |
| Novartis Pharmaceuticals Corporation | $24.49 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087145528 | CMS |
| SK Life Science, Inc. | $28.52 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154129037 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.99 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151757672 | CMS |
| UCB, Inc. | $41.14 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143014012 | CMS |
| UCB, Inc. | $32.32 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143014014 | CMS |
| UCB, Inc. | $17.78 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143014016 | CMS |
| UCB, Inc. | $35.96 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143014018 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.